Bubble drugs could revolutionise care

Ultrasound and micro-bubbles could be the answer to improving the effectiveness of many drugs, according to a prize-winning British engineer.

Professor Eleanor Stride, from Oxford University, has told how she is developing bubble cases for drugs to enable them to drift in the blood stream without being activated.

She proposes to use ultrasound to activate drugs when they are close to their target.

Professor Stride has now won a £300,000 engineering prize – intended to help her continue her research – from the Institution of Engineering and Technology.

Professor Stride said: “We are still at a very early stage but our recent results suggest that we can vastly improve the way we deliver existing drugs – and that this could be far more effective in the long run than inventing new cures.

"Currently, when drugs are injected, for example in the treatment of cancer or stroke, only a tiny percentage actually reaches the site of the disease. The rest of the drug will affect healthy tissue and can lead to extremely unpleasant side effects.

"If we can maximise the amount of drug in the target area we can both drastically improve their efficacy – and reduce these side effects."

She added: “The sense of achievement if we can get this working in the clinic and helping patients would be fantastic.

"We are tremendously excited by the recent discoveries our team has made in fabricating microparticles that can be activated by ultrasound for controlled drug release – and the prize will enable us to develop this research into usable technology that can improve delivery of conditions such as cancer and stroke.”

, ,

Leave a Reply

Your email address will not be published. Required fields are marked *

Search

Categories

Monthly Posts

Our Clients

BSH
Practice Index